Loading...

Intracellular Staining Permeabilization Wash Buffer (10X)

Pricing & Availability
Regulatory Status
RUO
Other Names
Perm/Wash, Permeabilization Buffer
Ave. Rating
Submit a Review
Product Citations
publications
Cat # Size Price Quantity Check Availability Save
421002 100 mL 76€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

Intracellular Staining Permeabilization Wash Buffer is useful for intracellular staining procedures, e.g., in preparation of cells for staining intracellular cytokines or other proteins. Intracellular Staining Permeabilization Wash Buffer is used to permeabilize cells following fixation with Intracellular Staining Fixation Buffer (Cat. No. 420801). It is supplied as a 10X solution and should be diluted in deionized water prior to use. Intracellular Staining Permeabilization Wash Buffer has been formulated to have minimal effects on cells, reduce non-specific staining and enhance the signal to noise ratio. It can be used for antibody dilutions and cell washing during intracellular staining.

Product Details
Technical Data Sheet (pdf)

Product Details

Storage & Handling
The Intracellular Staining Perm wash buffer solution should be stored between 2°C and 8°C. Do not freeze.
Application

ICC, ICFC - Quality tested
IHC - Reported in the literature, not verified in house
Recommended Usage

For use in permeabilization, dilute Intracellular Staining Permeabilization Wash Buffer (10X) to 1X in DI water. Resuspend fixed cells in diluted Intracellular Staining Permeabilization Wash Buffer and centrifuge at 350 xg for 5-10 minutes, and repeat the process twice. It is recommended that the reagent be titrated for optimal performance for each application. Please see "Intracellular Cytokine Staining Protocol" on BioLegend's website for more details.

Application Notes

The Intracellular Staining Permeabilization Wash Buffer (10X) may have crystallization or precipitation observed when it is stored at 2-8°C; however, this is normal and does not affect the buffer's performance. If there is heavy precipitation observed after dilution to 1X working solution, the buffer can be filtered to clarify the solution.

Application References

(PubMed link indicates BioLegend citation)
  1. Smeltz RB. 2007. J. Immunol. 178:4786.
  2. Kang YJ, et al. 2007. Nature Immunol. 8:601.
  3. del Rio ML, et al. 2011. Transplantation. 92:1085. PubMed
  4. del Rio ML, et al. 2012. J. Immunol. 188:4885. PubMed
  5. Marongiu L, et al. 2013. PLoS One. 8:75684. PubMed
  6. Xiao Z, et al. 2013. Mol Immunol. 56:423. PubMed
  7. Kusner LL, et al. 2014. PLoS One. 9:102231. PubMed
  8. Ni PP, et al. 2014. J Immunol. 193:1778. PubMed
Product Citations
  1. Li B, Schmidt N 2016. PLoS One. 11: 0162427. PubMed
  2. Darzianiazizi M, et al. 2020. Int J Mol Sci. 21:00. PubMed
  3. Kim S, et al. 2020. Development. 147:00:00. PubMed
  4. Dumauthioz N, et al. 2020. Cell Mol Immunol. . PubMed
  5. Rappazzo CG, et al. 2020. bioRxiv. . PubMed
  6. Zhuo Y, et al. 2022. J Immunother Cancer. 10:. PubMed
  7. Chen R, et al. 2022. J Mol Cell Biol. 14:. PubMed
  8. Tang J, et al. 2022. Sci Immunol. 7:eadd4853. PubMed
  9. Shen M, et al. 2022. Adv Sci (Weinh). 9:e2203523. PubMed
  10. Hajnik RL, et al. 2022. Sci Transl Med. 14:eabq1945. PubMed
  11. Frost JN, et al. 2022. Sci Adv. 8:eabq5384. PubMed
  12. Li L, et al. 2022. Cancer Immunol Res. 10:1475. PubMed
  13. Deák P, et al. 2022. Cell Rep. 41:111563. PubMed
  14. Stokes JV, et al. 2022. Curr Protoc. 2:e584. PubMed
  15. Jia DJ, et al. 2022. Gut Microbes. 14:2145843. PubMed
  16. Gao L, et al. 2023. J Nanobiotechnology. 21:56. PubMed
  17. Kodama N, et al. 2023. Front Nutr. 10:1081263. PubMed
  18. Mohamed GA, et al. 2023. Breast Cancer Res. 25:23. PubMed
  19. Varun K, et al. 2023. EBioMedicine. 90:104516. PubMed
  20. Wang YH, et al. 2023. Int J Mol Sci. 24:. PubMed
  21. Deng G, et al. 2023. Cancers (Basel). 15:. PubMed
  22. Wang Y, et al. 2023. iScience. 26:106630. PubMed
  23. Changsheng H, et al. 2023. Sci Adv. 9:eade4186. PubMed
  24. Ruan H, et al. 2023. Acta Pharm Sin B. 13:2202. PubMed
  25. Zhang TR, et al. 2023. Pharmaceuticals (Basel). 16:. PubMed
  26. Komoto S, et al. 2023. Cancers (Basel). 15:. PubMed
  27. Peng, Q., Jiang, P., et al. 2025. Gut Microbes. 17(1),2541028. PubMed
  28. Zhang, N., Li, C., et al. 2025. Cell Death Dis. 17(1),115. PubMed
  29. Hanga MP, et al. 2021. Biotechnol Bioeng. 118:3175. PubMed
  30. Arbues A, et al. 2020. PLoS Pathog. 16:e1008312. PubMed
  31. Kim J, et al. 2021. Cytometry A. 99:807. PubMed
  32. Sulaj A, et al. 2022. J Clin Endocrinol Metab. 107:2167. PubMed
  33. Brog RA, et al. 2022. Cancer Immunol Res. 10:962. PubMed
  34. Nozaki K, et al. 2022. Nature. 606:960. PubMed
  35. Shemesh A, et al. 2022. J Exp Med. 219: . PubMed
  36. Yin XY, et al. 2023. Neural Regen Res. 18:213. PubMed
  37. Blanas A, et al. 2022. iScience. 25:104719. PubMed
  38. Bates TA, et al. 2022. Cell Rep. 41:111544. PubMed
  39. Gong YY, et al. 2022. Cancer Res Commun. 2:842. PubMed
  40. Liang Y, et al. 2022. Theranostics. 12:7729. PubMed
  41. Wang Y, et al. 2022. Front Endocrinol (Lausanne). 13:1036517. PubMed
  42. Koutník J, et al. 2022. Front Immunol. 13:1049033. PubMed
  43. Minott JA, et al. 2022. Front Immunol. 13:1038340. PubMed
  44. Tan TCJ, et al. 2022. Nat Commun. 13:7796. PubMed
  45. Phares TW, et al. 2022. Front Pharmacol. 13:1029636. PubMed
  46. Zhao X, et al. 2022. STAR Protoc. 3:101859. PubMed
  47. Chan L, et al. 2022. Cells. 12: . PubMed
  48. Ding D, et al. 2023. J Med Chem. 66:1467. PubMed
  49. Qin S, et al. 2023. Acta Pharm Sin B. :. PubMed
  50. Sun L, et al. 2023. Mol Med Rep. 27: . PubMed
  51. Di Benedetto C, et al. 2023. Cancers (Basel). 15: . PubMed
  52. Chan L, et al. 2023. Int J Mol Sci. 24: . PubMed
  53. Xiao JF, et al. 2022. Mol Cancer Res. 20:637. PubMed
  54. Shen JZ, et al. 2022. Mol Cell. 82:1123. PubMed
  55. Guo H, et al. 2022. Biomaterials. 283:121441. PubMed
  56. Zhang H, et al. 2022. J Exp Med. 219:. PubMed
  57. Bronge M, et al. 2022. Sci Adv. 8:eabn1823. PubMed
  58. Lentucci C, et al. 2017. J Biol Chem. 292:2754-2772. PubMed
  59. Glaser K, et al. 2015. Immunol Lett. 166: 19-27. PubMed
  60. Kusner L, et al. 2014. PLoS One. 9:102231. PubMed
  61. Li Q, et al. 2022. Cell Rep. 40:111308. PubMed
  62. van Vloten JP, et al. 2022. J Immunother Cancer. 10:. PubMed
  63. Lebedeva IV, et al. 2021. Cell Death Dis. 12:770. PubMed
  64. Zhang L, et al. 2021. J Immunol. 207:590. PubMed
  65. Li X, et al. 2022. Nat Commun. 13:2794. PubMed
  66. Khayrullina G, et al. 2020. Skelet Muscle. 10:16. PubMed
  67. Spitzer SO, et al. 2019. Neuron. 101:459. PubMed
  68. Li L,et al. 2017. Sci Rep.. 10.1038/s41598-017-14000-z. PubMed
  69. Zhang Y, et al. 2020. Oncol Lett. 1.053472222. PubMed
  70. Stewart CA, et al. 2020. bioRxiv. . PubMed
  71. Stewart CA, et al. 2021. J Thorac Oncol. Online ahead of prin. PubMed
  72. Kiritsy MC, et al. 2021. Elife. 10:. PubMed
  73. Poli V, et al. 2021. iScience. 24:103256. PubMed
  74. Duan Q, et al. 2021. Front Cell Dev Biol. 9:761193. PubMed
  75. Stegelmeier AA, et al. 2022. Biomedicines. 10:. PubMed
  76. Zhang S, et al. 2022. Cell Death Dis. 13:844. PubMed
  77. Huang X, et al. 2019. Cancer Immunol Res. 1.388888889. PubMed
  78. Angiari S, et al. 2020. Cell Metab. 31:391. PubMed
  79. Jacob A, et al. 2020. Nature Protocols. 14(12):3303-3332.. PubMed
  80. Haque M, et al. 2021. STAR Protoc. 2:100264. PubMed
  81. Tsai CY, et al. 2022. J Biomed Sci. 29:47. PubMed
  82. Gärtner F, et al. 2021. Front Immunol. 12:745132. PubMed
  83. Gao F, et al. 2021. Front Cell Infect Microbiol. 10:593805. PubMed
  84. Martinez-Usatorre A, et al. 2020. Front Immunol. 11:340. PubMed
  85. Martinez–Usatorre A, et al. 2019. Cancer Immunol Res. 0.995138889. PubMed
  86. Goyal S, et al. 2017. Sci Rep. . 10.1038/s41598-017-18046-x. PubMed
  87. Tang B, et al. 2020. Clin Cancer Res. 26:2216. PubMed
  88. Jtte BB, et al. 2021. iScience. 24(8):102833. PubMed
  89. Herda S, et al. 2021. Int J Cancer. 148:3097. PubMed
  90. Lau H, et al. 2021. Int J Mol Sci. 22:. PubMed
  91. Zhou H, et al. 2022. J Clin Invest. 132:. PubMed
  92. Eslani M,et al. 2017. Invest Ophthalmol Vis Sci.. 58(12):5507-5517. PubMed
  93. Shinde MY, et al. 2017. J Biol Chem. 292:18240. PubMed
  94. Haryadi L, et al. 2019. Vet World. 12:1529. PubMed
  95. Ghose J, et al. 2018. Oncoimmunology. 7:e1486948. PubMed
  96. Zhang X, et al. 2020. J Immunol. 205:1743. PubMed
  97. Ni P, et al. 2014. J Immunol . 193:1778. PubMed
  98. Subham S, et al. 2022. Breast Cancer Res Treat. Online ahead of print. PubMed
  99. Lau H, et al. 2021. Xenotransplantation. 28:e12667. PubMed
  100. Su W, et al. 2022. Front Immunol. 13:952338. PubMed
  101. Ma Q, et al. 2022. Nat Commun. 13:4142. PubMed
  102. Datta A, et al. 2022. J Fungi (Basel). 8:. PubMed
  103. Jiang P, et al. 2021. Nat Methods. 18:1181. PubMed
  104. Zhan Y, et al. 2021. JCI Insight. 6:. PubMed
  105. Hendricks A, et al. 2021. Front Oncol. 11:646885. PubMed
  106. Shamsi F, et al. 2021. Nat Metab. 3:485. PubMed
  107. Sohrabi Y, et al. 2020. Front Immunol. 11:353. PubMed
  108. Martinez–Usatorre A, et al. 2018. J Immunol. 201:792. PubMed
  109. Xiao Z, et al. 2013. Mol Immunol. 56:423. PubMed
  110. Hilpert C, et al. 2016. J Immunol. 197: 2780 - 2786. PubMed
  111. Cheng K, et al. 2021. Nat Commun. 12:2041. PubMed
  112. Zhang X, et al. 2022. Theranostics. 12:1621. PubMed
  113. Berical A, et al. 2022. Nat Commun. 13:4270. PubMed
  114. Clancy–Thompson E, et al. 2018. Cancer Immunol Res. 1.308333333. PubMed
  115. Pearce V, et al. 2015. J Immunol. 195: 3206 - 3217. PubMed
  116. Zhang L, et al. 2021. Methods Mol Biol. 2388:175. PubMed
  117. Rodriguez S, et al. 2020. Xenotransplantation. 27:e12554. PubMed
  118. Chakraborty S, et al. 2022. Sci Transl Med. . PubMed
  119. Leonard NA, et al. 2021. Cancers (Basel). 13:. PubMed
  120. Chen L, et al. 2021. Cell Death Differ. 28:1880. PubMed
  121. Baek J, et al. 2017. Am J Pathol. 10.1016/j.ajpath.2017.02.011. PubMed
  122. Lau H, et al. 2020. Xenotransplantation. 27:e12555. PubMed
  123. Mkhikian H, et al. 2022. Nat Aging. 2:231. PubMed
  124. Li J, et al. 2022. J Tissue Eng. 13:20417314221127908. PubMed
  125. Lownik JC, et al. 2019. J Immunol. 202:664. PubMed
  126. Ouyang W, et al. 2021. Invest Ophthalmol Vis Sci. 62:25:00. PubMed
  127. Nausch N, et al. 2017. PLoS Negl Trop Dis. 11(2):e0005415. PubMed
  128. Xu Z, et al. 2016. Nat Commun. 7:10728. PubMed
  129. Ren Y, et al. 2022. J Immunother Cancer. 10:. PubMed
  130. Wei W, et al. 2022. mSystems. 7:e0046922. PubMed
  131. Zhao X, et al. 2022. Nat Protoc. 17:2240. PubMed
  132. Yang J, et al. 2022. Microbiome. 10:149. PubMed
  133. Alvandi Z, et al. 2022. J Am Heart Assoc. 11:e023695. PubMed
  134. van Duijn A, et al. 2021. Cancer Immunol Immunother. Online ahead of print. PubMed
  135. Jakic B, et al. 2021. Cell Death Dis. 12:187. PubMed
  136. Breznik JA, et al. 2018. Physiol Rep. 6:e13937. PubMed
  137. Page N, et al. 2021. Nat Commun. 12:1009. PubMed
  138. Gunasena M, et al. 2022. Sci Rep. 12:12377. PubMed
  139. Li Q, et al. 2017. Front Immunol. 0.797916667. PubMed
  140. Liu X, et al. 2016. Sci Rep. 6:36722. PubMed
  141. Rio M, et al. 2012. J Immunol. 188:4885. PubMed
  142. Hayes D, et al. 2022. JCI Insight. 7:. PubMed
  143. Gong C, et al. 2021. Mol Cell. 81:4059. PubMed
  144. Chen DL, et al. 2021. Mol Cancer. 20:166. PubMed
  145. Kim S, et al. 2020. Development. . PubMed
  146. Henrich IC, et al. 2021. Cancer Res. 81:2171. PubMed
  147. Kundu K, et al. 2019. Cancer Immunol Res. 1.069444444. PubMed
  148. Bajpai G, et al. 2018. Nat Med. 24:1234. PubMed
  149. Janela B, et al. 2019. Immunity. 50:1069. PubMed
  150. Wilmes A, et al. 2017. Toxicol In Vitro. 10.1016/j.tiv.2017.07.023. PubMed
  151. Rio M, et al. 2011. Transplantation. 92:1085. PubMed
  152. Hiza H, et al. 2021. Sci Rep. 11:13190. PubMed
  153. Wen T, et al. 2022. Cancer Immunol Res. 10:162. PubMed
  154. Ma K, et al. 2022. iScience. 25:104347. PubMed
  155. Chen YF, et al. 2019. J Biomed Sci. 26:85. PubMed
  156. Wang Y, et al. 2020. Virol Sin. 36:122. PubMed
  157. Lau H, et al. 2020. Islets. 41:12. PubMed
  158. Lau H, et al. 2020. PLoS One. 15:e0243506. PubMed
  159. Dong M, et al. 2022. J Immunother Cancer. 10:. PubMed
  160. Shemesh A, et al. 2022. J Exp Med. 219:. PubMed
  161. Teh MR, et al. 2021. Front Immunol. 12:714613. PubMed
  162. Haswell JR, et al. 2021. PLoS One. 16:e0252848. PubMed
  163. Wang G, et al. 2020. Nat Commun. 0.611111111. PubMed
  164. Park SR, et al. 2020. Cell Rep. 32:108077. PubMed
  165. Chen RH, et al. 2021. Front Immunol. 11:594775. PubMed
  166. Spiliopoulou P, et al. 2022. Mol Cancer Ther. . PubMed
  167. Tintos-Hernandez JA, et al. 2021. Brain Commun. 3:fcab215. PubMed
  168. Koutník J, et al. 2022. Cell Commun Signal. 20:54. PubMed
  169. Zhao X, et al. 2022. iScience. 25:104690. PubMed
  170. Cérbulo-Vázquez A, et al. 2022. PLoS One. 17:e0264566. PubMed
  171. Gao J, et al. 2022. Front Immunol. 13:955812. PubMed
  172. Ansari M, et al. 2017. Cell Signal. 10.1016/j.cellsig.2017.04.014. PubMed
  173. Ahmad S, et al. 2017. Prog Neuropsychopharmacol Biol Psychiatry. 10.1016/j.pnpbp.2017.06.034. PubMed
  174. Xia Y, et al. 2018. Cell. 175:1059. PubMed
  175. Lei L, et al. 2021. Front Cell Dev Biol. 659744:9. PubMed
  176. Frafjord A, et al. 2020. Scand J Immunol. e12889:92. PubMed
  177. Rhoades NS, et al. 2022. Cell Rep. 39:110725. PubMed
  178. Reuschl AK, et al. 2022. Cell Rep. 39:110650. PubMed
  179. Tatangelo V, et al. 2022. Front Oncol. 12:877495. PubMed
  180. Huang T, et al. 2022. Nat Commun. 13:3489. PubMed
  181. Deng Y, et al. 2021. Nat Commun. 12:7041. PubMed
  182. DiMuzio JM, et al. 2021. Vaccine X. 8:100098. PubMed
  183. Lee G, et al. 2021. Viruses. 13: . PubMed
  184. Lownik JC, et al. 2020. Biochem Biophys Rep. 24:100803. PubMed
  185. Labi V, et al. 2019. Genes Dev. 33:1673. PubMed
  186. Sun X, et al. 2017. Microbes Infect. 10.1016/j.micinf.2017.08.007. PubMed
  187. Hernandez AA, et al. 2020. J Immunol. 205:2806. PubMed
  188. Su Y, et al. 2020. Cell. 1479:183. PubMed
  189. Wawrzyniak M, et al. 2021. Pharmacol Res Perspect. 9:e00837. PubMed
  190. Mcgaw C, et al. 2022. Nat Commun. 13:2833. PubMed
  191. Wagner AK, et al. 2022. iScience. 25:105137. PubMed
  192. Zheng L, et al. 2020. Clin Cancer Res. 26:3694. PubMed
  193. Witt G, et al. 2020. Cell Biol Toxicol. . PubMed
  194. Marongiu L, et al. 2013. PLoS One. 8:75684. PubMed
  195. Sun Y, et al. 2022. iScience. 25:104846. PubMed
  196. van Loon K, et al. 2022. Cancers (Basel). 14:. PubMed
  197. Wang X, et al. 2022. Elife. 11:. PubMed
  198. Liu X, et al. 2021. Adv Sci (Weinh). 8:e2100233. PubMed
  199. Heckler M, et al. 2021. Cancer Discov. Online ahead of prin. PubMed
  200. Giadone RM, et al. 2018. Amyloid. 25:148. PubMed
  201. Gebremeskel S, et al. 2017. Cancer Immunol Res. 0.9625. PubMed
  202. Zhang Z, et al. 2021. Front Immunol. 12:699478. PubMed
  203. Spiljar M, et al. 2021. Cell Metab. 33:2231. PubMed
  204. Chen Y, et al. 2021. Braz J Med Biol Res. 54:e9570. PubMed
  205. Xiao C, et al. 2021. STAR Protoc. 2:100789. PubMed
  206. Chen S, et al. 2020. Cancer Immunol Res. 1064:8. PubMed
  207. Assadi G, et al. 2016. PLoS One. 11:e0168276. PubMed
  208. Ikebuchi R, et al. 2016. Sci Rep. 6:35002. PubMed
  209. Lei F, et al. 2012. J Vis Exp. 63: 3986. PubMed
  210. Guo Z, et al. 2022. Neurobiol Pain. 12:100096. PubMed
  211. Luvanda MK, et al. 2021. J Fungi (Basel). 7:. PubMed

Antigen Details

Antigen References

1. Current Protocols in Immunology (John Wiley & Sons New York) Unit 6.24 Detection of Intracellular Cytokines by Flow Cytometry (Barbara Foster and Calman Prussin NIAID NIH Bethesda MD).
2. Sander B, et al. 1991. Immunol. Rev. 119:65.
3. Sander B, et al. 1993. J. Immunol. Meth. 166:201.
4. Prussin C, et al. 1995. J. Immunol. Meth. 188:117.

Gene ID
NA

Related FAQs

There are no FAQs for this product.
Go To Top Version: 3    Revision Date: 08.26.2015

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account